481 Results (Page 11 of 20)
UK Markets Research Reports
UK Allergy Therapeutics Market Analysis
UK allergy therapeutics market was valued at $603 Mn in 2022 and is estimated to reach $851 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The increasing prevalence of allergic disorders and related health problems is driving the demand for allergy therapeutics. The major pharmaceutical companies that are presently performing in the market are GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, Novartis, Pfizer, Sanofi, Merck & Co., Roche, Boehringer Ingelheim and AbbVie.
UK Alcohol Addiction Therapeutics Market Analysis
The UK Alcohol Addiction Therapeutics Market is valued at around $19 Mn in 2022 and is projected to reach $26 Mn by 2030, exhibiting a CAGR of 4.3% during the forecast period. The major growth drivers of the UK alcohol addiction therapeutics market lie in the transition towards personalized treatment approaches, an evolving policy landscape, and a shifting focus on social determinants, expanding engagement with social welfare groups and community activities to address the multifaceted aspects of alcoholism. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in UK are Elli Lily, Roche, AbbVie, Lundbeck, Alkermes, Otsuka Pharmaceuticals, Hikma Pharmaceuticals, Pfizer, BioCorRx, Ethypharm, etc among others
UK Oncology Clinical Trials Market Analysis
UK oncology clinical trials market is projected to grow from $328.9 Mn in 2022 to $433.1 Mn by 2030, registering a CAGR of 3.50% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in the UK and efforts to promote research, collaboration, and innovation. The market is segmented by phase, study design, and indication. Some of the major players include Novartis AG, AstraZeneca & Astex Pharmaceuticals.
UK Obesity Drugs Market Analysis
This report presents a strategic analysis of the UK Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK Obesity Drugs Market, offering unmatched value, accuracy, and expert insights.
UK Medical Devices Market Analysis
This report presents a strategic analysis of the UK Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK Medical Devices Market, offering unmatched value, accuracy, and expert insights.
UK In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of the UK In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy, and expert insights.
UK Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the UK Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK Healthcare Reimbursement Market, offering unmatched value, accuracy, and expert insights.
UK Healthcare Insurance Market Analysis
UK's healthcare insurance market is projected to grow from $52.68 Bn in 2022 to $81.46 Bn by 2030, registering a CAGR of 5.6% during the forecast period of 2022-30. The main factors driving the growth would be the rising cost of medical services, the increasing number of daycare procedures, and government initiatives. The market is segmented by component, provider, coverage, health insurance plans, and end-user. Some of the major players include Bupa, Aviva, VitalityHealth, Simplyhealth and Saga.
UK ENT Devices Market Analysis
UK ENT Devices Market is projected to grow from $600 Mn in 2022 to $810 Mn by 2030, registering a CAGR of 3.8% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. Some of the key players in the UK ENT devices market include Otomagnetics, Keystone ENT, and AventaMed.
UK Coronary Stents Market Analysis
UK's Coronary Stents Market is expected to witness growth from $294 Mn in 2022 to $365 Mn in 2030 with a CAGR of 2.75% for the forecasted year 2022-30. In the UK, coronary artery disease affects a significant number of people, creating a serious health issue. The demand for coronary stents is anticipated to rise as the population ages and risk factors like obesity and diabetes become more common. The market is segmented by type and by gender. Some key players in this market include Renishaw, LivaNova, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
UK Contraceptive Devices Market Analysis
UK's Contraceptive Devices Market is expected to witness growth from $335 Mn in 2022 to $535 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. In the UK, people are becoming more aware of and accepting of contraceptive methods. Individuals are more likely to utilize contraceptives to avoid unwanted pregnancies as they become more aware of their alternatives. The market is segmented by type and by gender. Some key players in this market include Consilient Health, Renovos Biologics, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
UK Cardiovascular Diseases Therapeutics Market Analysis
UK's cardiovascular disease therapeutics market is projected to grow from $4.22 Bn in 2022 to $6.35 Bn in 2030 with a CAGR of 5.22% for the year 2022-30. Cardiovascular disease remains the major cause of death in the UK, also the development of new drugs for the treatment of cardiovascular diseases in the UK is the major growth driver of the market. The UK cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Ackerley Pharma, eXmoor Pharma, and Bristol-Myers Squibb are the major players in the UK cardiovascular disease therapeutics market.
UK Cardiovascular Drugs Market Analysis
UK Cardiovascular Drug Market is at around $3.56 Bn in 2022 and is projected to reach $4.15 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. Government initiatives to promote cardiovascular health and implement preventative measures may result in an increase in the market for cardiovascular medications. The market is dominated by key players like Bristol-Myers Squibb Co, Pfizer, Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca Inc., Sanofi-Aventis Inc., Novartis Pharmaceuticals, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
UK Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The UK Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $86 Mn in 2022, and is predicted to grow at (CAGR) of 5.8% from 2023 to 2030, to US $135 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, technological advancements, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as Janssen, Novartis, Roche, Sanofi, Pfizer Inc, and others
UK Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The UK Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $29 Mn in 2022 and is predicted to grow at (CAGR) of 3.8% from 2023 to 2030, to US $39 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of autosomal dominant polycystic kidney disease, unmet needs, government initiatives, and other factors. The industry is primarily dominated by players such as Otsuka, AceLink, Palladio, Reata, Xortx, Regulus, among others
UK Age-Related Macular Degeneration Therapeutics Market Analysis
The UK Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $281 Mn in 2022 and is predicted to grow at a CAGR of 6.90% from 2023 to 2030, to US $479 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, advancements in treatment, and other factors. Major players in the industry include Regeneron Pharmaceuticals, Novartis, Bayer, Roche, Genentech, and other notable companies.
UK Addiction Therapeutics Market Analysis
UK addiction therapeutics market was valued at $263 Mn in 2022 and is estimated to reach $385 Mn in 2030, exhibiting a CAGR of 4.9% during the forecast period. The addiction treatment industry is expanding due to a greater understanding and acceptance of substance use disorders as significant public health concerns. Major market players are Indivior, Reckitt Benckiser Pharmaceuticals, Camurus AB, Molteni Farmaceutici, Ethypharm, Martindale Pharma, Accord Healthcare, Sun Pharmaceutical Industries, Wockhardt UK and Martindale Pharma
UK Adult Malignant Glioma Therapeutics Market Analysis
The UK Adult Glioma Therapeutics Market is valued at around $57 Mn in 2022 and is projected to reach $98 Mn by 2030, exhibiting a CAGR of 6.9% during the forecast period. A powerful convergence of factors is driving the UK Adult Malignant Glioma Therapeutics Market, including an increasing glioma burden, an aging population, a focus on customized therapy, and active research and development initiatives, both by the government and other market players. Key players in the UK Adult Malignant Glioma Therapeutics Market include companies like Merck & Co., Bristol-Myers Squibb, Roche, AbbVie, Azurity Pharmaceuticals, Aptevo Therapeutics, Peptinib Ltd., Bio-Rad Laboratories, Novocure, Pfizer etc.
UK Over The Counter (OTC) Pharmaceuticals Market Analysis
The UK over-the-counter (OTC) pharmaceuticals market size was valued at $3575 Mn in 2022 and is estimated to expand at a CAGR of 3.54% from 2022 to 2030 and will reach $4722.2 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
UK ePharmacy Market Analysis
This report presents a strategic analysis of the UK ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UK ePharmacy Market, offering unmatched value, accuracy, and expert insights.
UK Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the UK Oncology Therapeutics Market will reach a value of $7.7 Bn from $4.7 Bn in 2022, growing at a CAGR of 6.4% during 2022-30. The Oncology Therapeutics Market in the UK is dominated by a few domestic pharmaceutical companies such as AstraZeneca, GlaxoSmithKline, and Scancell. The Oncology Therapeutics Market in the UK is segmented into different types of cancer and different therapy types. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for UK Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
UK Neurology Devices Market Analysis
UK Neurology Device Market size is at around $328.12 Mn in 2022 and is projected to reach $515.13 Mn in 2030, exhibiting a CAGR of 5.8% during the forecast period. UK has a high demand for Implantable Pulse Generators (IPGs) and Spinal Cord Stimulation (SCS) Devices that are well-minted by players like Johnson and Johnson, St. Jude Medical, and Boston Scientific. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
UK Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UK Liver Cancer Therapeutics market will reach a value of $242.9 Mn from $76.2 Mn in 2022, growing at a CAGR of 15.6% during 2022-30. Liver Cancer Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as GlaxoSmithKline, Oxford BioTherapeutics, AstraZeneca, and Jazz Pharmaceuticals. The Liver Cancer Therapeutics market in the UK is segmented into different types of cancer and different therapy types. Some of the major factors affecting the UK Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
UK Healthcare Claims Management Market Analysis
The UK healthcare claims management market is projected to grow from $694.2 Mn in 2022 to $3275.17 Mn by 2030, registering a CAGR of 21.4% during the forecast period of 2022-30. The main factors driving the growth would be increasing demand for healthcare services, rising healthcare costs, increasing use of Electronic Health Records (EHRs), and advances in technology. The market is segmented by component, type, by delivery mode, and end-user. Some of the major players include Healthcode, WNS, Healix Health Services, Cognizant, Allscripts Healthcare and McKesson.
UK 3D Printing Medical Devices Market Analysis
UK 3D printing medical devices market size was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.3% from 2022 to 2030 and will reach $ 225 Mn in 2030. The market is segmented by component, application, technology, and end user. This market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Renishaw plc, Sutrue, Axial3D, Adapttech, FDM Digital Solutions, 3D LifePrints, Opro Mouthguards, Toffeln, PrintLab, Added Scientific, and others.